日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Harnessing the microbiome for cancer therapy

利用微生物组进行癌症治疗

Hajjar, Roy; Mars, Ruben A T; Kashyap, Purna C

Roads and detours for CAR T cell therapy in autoimmune diseases

CAR-T细胞疗法在自身免疫性疾病治疗中的道路和弯路

Avouac, Jérôme; Barzel, Adi; Caiati, Delma; Davis, Randall S; Gottschalk, Stephen; Grieshaber-Bouyer, Ricardo; Mao, Xuming; Luning Prak, Eline T; Radic, Marko; Scherlinger, Marc; Suneja, Yatin; Talleur, Aimee; Thacker, Amber L; Unutmaz, Derya

Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial

美国一项多中心、随机、开放标签、非劣效性3期临床试验:质子放射疗法与光子放射疗法治疗口咽癌患者的疗效比较

Frank, Steven J; Busse, Paul M; Lee, J Jack; Rosenthal, David I; Hernandez, Mike; Swanson, David M; Garden, Adam S; Gunn, G Brandon; Patel, Samir H; Snider, James W; Ma, Daniel J; Molitoris, Jason K; Lee, Nancy Y; Parvathaneni, Upendra; McDonald, Mark W; Kalman, Noah S; Lin, Alexander; Mohammed, Nasiruddin; Henson, Christina; Hyde, Christian; Bajaj, Gopal K; Katz, Sanford R; Dagan, Roi; Morrison, William H; Reddy, Jay P; Fuller, C David; Shah, Shalin J; Phan, Jack; Chronowski, Gregory M; Mayo, Lauren; Sturgis, Erich M; Ferrarotto, Renata; Zhu, Xiaorong R; Zhang, Xiaodong; Wang, Li; Hutcheson, Katherine A; El-Naggar, Adel K; Moreno, Amy C; Lee, Anna; Spiotto, Michael T; Gross, Neil D; Lai, Stephen Y; Liao, Jay J; Paly, Jonathan; Liao, Zhongxing; Foote, Robert L

Materials Advances for Distributed Environmental Sensor Networks at Scale

大规模分布式环境传感器网络材料进展

Madsen, Kenneth E; Flavin, Matthew T; Rogers, John A

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges

卡博特韦联合利匹韦林治疗 HIV 感染者及依从性挑战

Rana, Aadia I; Zheng, Lu; Castillo-Mancilla, Jose; Bao, Yajing; Sieczkarski, Sara; Brooks, Kristina M; Lake, Jordan E; Fichtenbaum, Carl; Heath, Sonya L; Belaunzaran-Zamudio, Pablo F; Klingman, Karin; Fox, Lawrence; Morton, Tia; Stirratt, Michael; Li, Jonathan Z; Acosta, Edward P; Venuto, Charles; Galárraga, Omar; Shoptaw, Steven; Wohl, David; Green, Madison; Beijer, Ceora; Ferbas, Kathie; Jennings, Cheryl; Shin, Katherine; Collahua, Romina; Dorosh, Michael; Wannamaker, Paul; D'Amico, Ronald; Smith, Kimberly; Spreen, William; Vandermeulen, Kati; Van Solingen-Ristea, Rodica; Wimbish, Chanelle; Tashima, Karen T; Landovitz, Raphael J

Mental Health Outcomes in Children after Parental Firearm Injury

父母枪伤后儿童的心理健康状况

Karandinos, George; Giuriato, Mia; Zubizarreta, José R; Koh, Katherine A; Masiakos, Peter T; Song, Zirui; Sacks, Chana A

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

非小细胞肺癌软脑膜转移的演变格局:一项国际性、当代、多中心队列研究

Zheng, M M; Xia, Y; Pan, K; Sun, F; Tan, A C; Dong, X R; Tu, H Y; Tang, L B; Li, Y S; Yin, K; Borgeaud, M; Singhal, S; Zhu, E; Zhang, J; Nilsson, M; Wu, J; Gibbons, D L; Wakelee, H; Neal, J W; Lee, J; Vaporciyan, A A; Ringsurongkawong, W; Tran, H T; Zhang, R Z; Zhang, T; Zhou, Q; Zhong, W Z; Li, W; Zhang, Y C; Riess, J W; Addeo, A; Heymach, J V; Myall, N; Tan, D; Wu, Y L; Le, X

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial

CheckMate 9ER 随机 III 期试验中,对纳武利尤单抗联合卡博替尼治疗晚期肾细胞癌的最终分析

Motzer, R J; Escudier, B; Burotto, M; Powles, T; Apolo, A B; Bourlon, M T; Shah, A Y; Porta, C; Suárez, C; Barrios, C H; Richardet, M; Gurney, H; Kessler, E R; Tomita, Y; Bedke, J; Scheffold, C; Askelson, M; Panzica, J; Zhang, J; van Kooten Losio, M; Choueiri, T K

A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)

一项多中心随机 II 期试验,比较乐伐替尼联合依维莫司与卡博替尼治疗 PD-1 免疫检查点抑制剂治疗后进展的转移性透明细胞肾细胞癌患者的疗效(LenCabo)

Hahn, A W; Chahoud, J; Skelton, W P; Yuan, Y; Zurita-Saavedra, A J; Kovitz, C; Alhalabi, O; Campbell, M T; Jonasch, E; Lin, J K; Desai, M; Santos, M J M N; Hwang, H; Corn, P G; Msaouel, P; Tannir, N M

MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies

MTAP缺失在癌基因驱动的非小细胞肺癌中很常见,并可能使肿瘤对PRMT5抑制剂和靶向治疗联合治疗敏感。

Aldea, M; Lenahan, S; Locquet, M-A; Liao, L; Gasparro, M; Gokhale, P C; Ghigna, M-R; Ionescu, D N; Odintsov, I; Ngo, K; Wang, X; Aziz, S; Pecci, F; Garbo, E; Ivanova, E; Nakazawa, S; Kulesza, J; Tsai, J A; Zullo, L; Lee, J; Zielinska, M; Simon, S; Han, D; Marinello, A; Li, G; Rossato de Almeida, G; Huang, J; Paoloni, F; Gariazzo, E; Santo, V; Remon, J; Marks, J A; LoPiccolo, J; Florez, N; Nishino, M; Ricciuti, B; Luo, J; Barbie, D A; Planchard, D; Rotow, J K; Barlesi, F; Graf, R P; Feng, W W; Besse, B; Paweletz, C; Sholl, L; Shaw, A T; Jänne, P A